Watts Gwilliam & Co’s Thermo Fisher Scientific TMO Stock Holding History

Watts Gwilliam & Co’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-439	Closed	-$218K	–	238
2025 Q1	$218K	Buy	+439	New	+$238K	0.05%	192
2024 Q4	–	Sell	-356	Closed	-$212K	–	227
2024 Q3	$212K	Buy	+356	New	+$211K	0.05%	189
2024 Q1	$200K	Buy	+337	New	+$189K	0.06%	169

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Watts Gwilliam & Co's TMO Position: Q2 2025 in Review

Watts Gwilliam & Co sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 439 shares — an estimated $218K sold.

Watts Gwilliam & Co first reported a position in TMO in Q1 2024 and held it in 3 quarters. The position peaked at $218K in Q1 2025. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Watts Gwilliam & Co reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Watts Gwilliam & Co sold 439 Thermo Fisher Scientific shares in Q2 2025, an estimated $218K.
Watts Gwilliam & Co first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 3 quarters.
Watts Gwilliam & Co's Thermo Fisher Scientific position peaked at $218K in Q1 2025.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Watts Gwilliam & Co's 13F filing for Q2 2025, filed 19 Sep 2025.